MétaCan
Menu
Back to cohort
Record W2947037085 · doi:10.3389/fonc.2019.00458

Observational Studies on the Association Between Post-diagnostic Metformin Use and Survival in Ovarian Cancer: A Systematic Review and Meta-Analysis

2019· review· en· W2947037085 on OpenAlexaboutno aff
Ting‐Ting Gong, Qi‐Jun Wu, Bei Lin, Shikai Ruan, Miki Kushima, Masafumi Takimoto

Bibliographic record

VenueFrontiers in Oncology · 2019
Typereview
Languageen
FieldBiochemistry, Genetics and Molecular Biology
TopicMetabolism, Diabetes, and Cancer
Canadian institutionsnot available
FundersShengjing HospitalNational Institutes of HealthFogarty International CenterDoctoral Start-up Foundation of Liaoning ProvinceChina Medical UniversityChina Postdoctoral Science FoundationNational Natural Science Foundation of ChinaVanderbilt University
KeywordsMetforminMedicineHazard ratioMeta-analysisObservational studyInternal medicineOncologyCohort studyConfidence intervalProspective cohort studyProportional hazards modelDiabetes mellitusCancerInsulinEndocrinology

Abstract

fetched live from OpenAlex

Objectives To summarize and quantify the relationship between post-diagnostic metformin use and ovarian cancer (OC) survival. Methods We systematically conducted an updated meta-analysis based on observational studies published up to December 31, 2018, identified from PubMed and Web of Science. Two team members independently extracted data and assessed the quality of each study. Summary Hazard ratios (HR) and 95% confidence intervals (CI) were calculated using a random-effects model. Results Five cohort studies including 3582 OC patients were included. All studies were graded as low risk of bias according to the Newcastle-Ottawa quality assessment scale. Post-diagnostic metformin use was associated with improved overall survival (summarized HR=0.42, 95% CI=0.31–0.56; I2=0%, P=0.842) and progression-free survival (summarized HR=0.69, 95% CI=0.45–1.07; I 2=61.9%, P=0.049) of OC patients. For OC patients with diabetes, post-diagnostic metformin use was associated with improved overall survival (summarized HR=0.51, 95% CI=0.28–0.95; I2=47.6%, P=0.149) and progression-free survival (summarized HR=0.38, 95% CI=0.27–0.55; I2=0%, P=0.594). No significant publication bias was detected in these analyses. Conclusions Post-diagnostic metformin use is consistently associated with better survival of OC patients regardless of diabetes status. Studies with larger sample sizes and prospective designs are required to confirm these findings and obtain detailed information, including standardized references for comparison, intensity and dose of metformin use, and further adjustment for potential confounders.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.003
metaresearch head score (Gemma)0.005
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Meta-analysis · Consensus signal: none
GenreCandidate signal: Review · Consensus signal: Review
Teacher disagreement score0.499
Threshold uncertainty score0.933

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0030.005
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0060.001
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.183
GPT teacher head0.395
Teacher spread0.212 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designMeta-analysis
Domainnot available
GenreReview

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations30
Published2019
Admission routes1
Has abstractyes

Explore more

Same venueFrontiers in OncologySame topicMetabolism, Diabetes, and CancerFrench-language works237,207